The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry International

Volumn 55, Issue 4, 2009, Pages 199-207

  Andrade da Costa, Belmira Lara da Silveira ^b   Kang, Kui Dong ^a   Rittenhouse, Kay D ^c   Osborne, Neville N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DEPARTAMENTO DE MICOLOGIA   (Brazil)

^c PFIZER INC   (United States)

Author keywords

Apoptosis; Butaprost; Neuroprotection; PGE2 receptors; Retinal cell cultures; Serum deprivation

Indexed keywords

BUTAPROST; CALBINDIN; CYCLIC AMP; LACTATE DEHYDROGENASE; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN RECEPTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR SUBTYPE; VIMENTIN; 4 AMINOBUTYRIC ACID; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; ANIMAL; BLOOD; CELL CULTURE; COCULTURE; CYTOLOGY; DNA DAMAGE; DRUG POTENTIATION; GLIA; METABOLISM; NERVE CELL; NEWBORN; PHYSIOLOGY;

RATTUS;

ALPROSTADIL; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, THY-1; APOPTOSIS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; CYCLIC AMP; DINOPROSTONE; DNA DAMAGE; GAMMA-AMINOBUTYRIC ACID; IN SITU NICK-END LABELING; L-LACTATE DEHYDROGENASE; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, PROSTAGLANDIN E; RETINA; VIMENTIN;

EID: 67349205846     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.02.015     Document Type: Article

References (69)

1. Abramovitz M., Adam M., Boie Y., Carriere M., Denis D., Godbout C., Lamontagne S., Rochette C., Sawyer N., Tremblay N.M., Belley M., Gallant M., Dufresne C., Gareau Y., Ruel R., Juteau H., Labelle M., Ouimet N., and Metters K.M. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483 (2000) 285-293
2. Ahmad A.S., Ahmad M., de Brum-Fernandes A.J., and Doré S. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res. 1066 (2005) 71-77
3. Álvaro A.R., Martins J., Araújo I.M., Rosmaninho-Salgado J., Santiago A.R., Martins J., Aveleira C., Santos P.F., Pereira T., Gouveia D., Carvalho A.L., Grouzmann E., Ambrósio A.F., and Cavadas C. NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Müller cells. J. Neurochem. 50 (2007) 757-763
4. Álvaro A.R., Martins J., Araújo I.M., Rosmaninho-Salgado J., Ambrósio A.F., and Cavadas C. Neuropeptide Y stimulates retinal neural cell proliferation-involvement of nitric oxide. J. Neurochem. 105 (2008) 2501-2510
5. Akaike A., Kaneko S., Tamura Y., Nakata N., Shiomi H., Ushikubi F., and Narumiya S. Prostaglandin E2 protects cultured cortical neurons against N-methyl-d aspartate receptor mediated glutamate cytotoxicity. Brain Res. 663 (1994) 237-243
6. Ayalasomayajula S.P., Amrite A.C., and Kompella U.B. Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. Eur. J. Pharmacol. 498 (2004) 275-278
7. Beale R., Nicholas D., Neuhoff V., and Osborne N.N. The binding of tetanus toxin to retinal cells. Brain Res. 248 (1982) 141-149
8. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., Pozzan T., and Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391 (1998) 281-285
9. Bilak M., Wu L., Wang Q., Haughey N., Conant K., St. Hillaire C., and Andreasson K. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann. Neurol. 56 (2004) 240-248
10. Biswas S., Bhattacherjee P., and Paterson C.A. Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues-a comparative immunohistochemical study. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 277-288
11. Caggiano A.O., and Kraig R.P. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1β production. J. Neurochem. 72 (1999) 565-575
12. Carrasco E., Casper D., and Werner P. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity. J. Neurosci. Res. 85 (2007) 3109-3117
13. Carrasco E., Werner P., and Casper D. Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress. Neurosci. Lett. 441 (2008) 44-49
14. Carter W.O., Narayanan P.K., and Robinson J.P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55 (1994) 253-258
15. Cazevieille C., Muller A., Meynier F., Dutrait N., and Bonne C. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24 (1994) 395-398
16. Chaum E. Retinal neuroprotection by growth factors: a mechanistic perspective. J. Cell. Biochem. 88 (2003) 57-75
17. Cheng T., Wei Cao W., Wen R., Steinberg R.H., and LaVail M.M. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat muller cells. Invest. Ophthalmol. Vis. Sci. 39 (1998) 581-591
18. Chidlow G., Wood J.P., Manavis J., Osborne N.N., and Casson R.J. Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest. Ophthalmol. Vis. Sci. 49 (2008) 762-771
19. Di Cesare A., Del Piccolo P., Zacchetti D., and Grohovaz F. EP2 receptor stimulation promotes calcium responses in astrocytes via activation of the adenylyl cyclase pathway. Cell. Mol. Life Sci. 63 (2006) 2546-2553
20. Echeverria V., Clerman A., and Doré S. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. Eur. J. Neurosci. 22 (2005) 2199-2206
21. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119 (1992) 493-501
22. Gendron T.F., Brunette E., Tauskela J.S., and Morley P. The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection. Eur. J. Pharmacol. 517 (2005) 17-27
23. Hata A.N., and Breyer R.M. Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation. Pharmacol. Ther. 103 (2004) 147-166
24. Higuchi M., Prosle R.J., and Yeh E.T. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 17 (1998) 2515-2524
25. Ishimoto I., Kiyama H., Hamano K., Shiosaka S., Malbon C.C., Nakauchi M., Emson P.C., Manabe R., and Tohyama M. Co-localization of adrenergic receptors and vitamin-d-dependent calcium-binding protein (calbindin) in the dopaminergic amacrine cells of the rat retina. Neurosci. Res. 7 (1989) 257-263
26. Izumi Y., Izumi M., Benz A.M., and Zorumski C.F. Lactate dehydrogenase release is facilitated by brief sonication of rat hippocampal slices and isolated retinas following acute neuronal damage. J. Neurosci. Methods 108 (2001) 49-55
27. Ji D., Li G.Y., and Osborne N.N. Nicotinamide attenuates retinal ischemia and light insults to neurones. Neurochem. Int. 52 (2008) 786-798
28. Ju W.K., Kim K.Y., and Neufeld A.H. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp. Eye Res. 77 (2003) 137-145
29. Jung S.H., Kang K.D., Ji D., Fawcett R.J., Safa R., Kamalden T.A., and Osborne N.N. The flavonoid baicalin counteracts ischemic and oxidative insults to retinal cells and lipid peroxidation to brain membranes. Neurochem. Int. 53 (2008) 325-337
30. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., Kunz A., Cho S., Orio M., and Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 12 (2006) 225-229
31. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., and Baik E.J. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J. Neurosci. Res. 70 (2002) 97-107
32. Kroemer G., Petit P., Zamzami N., Vayssiere J.L., and Mignotte B. The biochemistry of programmed cell death. FASEB J. 9 (1995) 1277-1287
33. Kroemer G. Mitochondrial control of apopotosis: an introduction. Biochem. Biophys. Res. Commun. 304 (2003) 433-435
34. Lee E.O., Shin Y.J., and Chong Y.H. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor. J. Neuroimmunol. 155 (2004) 21-31
35. Leung C.K., Lindsey J.D., Crowston J.G., Lijia C., Chiang S., and Weinreb R.N. Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy. Invest. Ophthalmol. Vis. Sci. 49 (2008) 4898-4902
36. Liu D., Wu L., Breyer R., Mattson M.P., and Andreasson K. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann. Neurol. 57 (2005) 758-761
37. Maihöfner C., Schlötzer-Schrehardt U., Gühring H., Zeilhofer H.U., Naumann G.O., Pahl A., Mardin C., Tamm E.R., and Brune K. Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest. Ophthalmol. Vis. Sci. 11 (2001) 2616-2624
38. Matsuo T., and Cynader M.S. The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle. Br. J. Ophthalmol. 77 (1993) 110-114
39. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R.M., and Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J. Neurosci. 24 (2004) 257-268
40. Mori A., Saito M., Sakamoto K., Narita M., Nakahara T., and Ishii K. Stimulation of prostanoid IP and EP(2) receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats. Eur. J. Pharmacol. 570 (2007) 135-141
41. Mukhopadhyay P., Bian L., Yin H., Bhattacherjee P., and Paterson C.A. Localization of EP1 and FP receptors in human ocular tissues by in situ hybridization. Invest. Ophthalmol. Vis. Sci. 42 (2001) 424-428
42. Najarian T., Hardy P., Hou X., Lachapelle J., Doke A., Gobeil Jr. F., Roy M.S., Lachapelle P., Varma D.R., and Chemtob S. Preservation of neural function in the perinate by high PGE(2) levels acting via EP(2) receptors. J. Appl. Physiol. 89 (2000) 777-784
43. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
44. Naskar R., Wissing M., and Thanos S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2962-2968
45. Naveh N., Belkin M., Ben-Chaim O., Weissman C., and Treister G. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment. Ophthalmic Res. 22 (1990) 3-11
46. Naveh N., Peer J., Bartov E., and Weissman C. Argon laser irradiation of rabbits' eyes-changes in prostaglandin E2 levels. Prostaglandins 41 (1991) 143-155
47. Nilsson S.F.E., Drecoll E., Tjen-Drecoll E.L., Toris C.B., Krauss A.H.-P., Kharlamb A., Nieves A., Guerra T., and Woodward D.F. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci. 47 (2006) 4042-4049
48. Osborne N.N., Casson R.J., Wood J.P., Chidlow G., Graham M., and Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23 (2004) 91-147
49. Osborne N.N., Chidlow G., Nash M.S., and Wood J.P. The potential of neuroprotection in glaucoma treatment. Curr. Opin. Ophthalmol. 10 (1999) 82-92
50. Osborne, N.N., Li, G.-Y., Ji, D., Andrade da Costa, B.L., Fawcett, R.J., Kang, K.D., Rittenhouse, K., in press. Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia. Invest. Ophthalmol. Vis. Sci.
51. Pooler A.M., Arjona A.A., Lee R.K., and Wurtman R.J. Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia. Neurosci. Lett. 362 (2004) 127-130
52. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 18 (1999) 39-57
53. Schlötzer-Schrehardt U., Zenkel M., and Nüsing R.M. Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1475-1487
54. Sennlaub F., Valamanesh F., Vazquez-Tello A., El-Asrar A.M., Checchin D., Brault S., Gobeil F., Beauchamp M.H., Mwaikambo B., Courtois Y., Geboes K., Varma D.R., Lachapelle P., Ong H., Behar-Cohen F., and Chemtob S. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108 (2003) 198-204
55. Sharif N.A., Williams G.W., Crider J.Y., Xu S.X., and Davis T.L. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes. J. Ocul. Pharmacol. Ther. 20 (2004) 489-508
56. Shimazawa M., Yamashima T., agarwal N., and Hara H. Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res. 1053 (2005) 185-194
57. Takadera T., Shiraishi Y., and Ohyashiki T. Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons. Neurochem. Int. 45 (2004) 713-719
58. Takadera T., Yumoto H., Tozuka Y., and Ohyashiki T. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci. Lett. 317 (2002) 61-64
59. Tezel G., and Wax M.B. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2660-2667
60. Toyomoto M., Ohta M., Okumura K., Yano H., Matsumoto K., Inoue S., Hayashi K., and Ikeda K. Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett. 562 (2004) 211-215
61. Verardo M.R., Lewis G.P., Takeda M., Linberg K.A., Byun J., Luna G., Wilhelmsson U., Pekny M., Chen D.F., and Fisher S.K. Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest. Ophthalmol. Vis. Sci. 49 (2008) 3659-3665
62. Versaux-Botteri C., Pochet R., and Nguyen-Legros J. Immunohistochemical localization of GABA-containing neurons during postnatal development of the rat retina. Invest. Ophthalmol. Vis. Sci. 30 (1989) 652-659
63. Vrabec J.P., and Levin L.A. The neurobiology of cell death in glaucoma. Eye 21 Suppl. 1 (2007) S11-S14
64. Wood J.P., Chidlow G., Graham M., and Osborne N.N. Energy substrate requirements for survival of rat retinal cells in culture: the importance of glucose and monocarboxylates. J. Neurochem. 93 (2005) 686-697
65. Wright D.H., Abran D., Bhattacharya M., Hou X., Bernier S.G., Bouayad A., Fouron J.C., Vazquez-Tello A., Beauchamp M.H., Clyman R.I., Peri K., Varma D.R., and Chemtob S. Prostanoid receptors: ontogeny and implications in vascular physiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) 1343-1360
66. Yang Z., Zhang Q., Ge J., and Tan Z. Protective effects of tetramethylpyrazine on rat retinal cell cultures. Neurochem. Int. 52 (2008) 1176-1187
67. Yuan L., and Neufeld A.H. Activated microglia in the human glaucomatous optic nerve head. J. Neurosci. Res. 64 (2001) 523-532
68. Zhang J., and Rivest S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur. J. Neurosci. 11 (1999) 2651-2668
69. Zhao C., and Shichi H. Immunocytochemical localization of prostaglandin E2 receptor subtypes in porcine ocular tissues. II. Nonuveal tissues. J. Ocul. Pharmacol. Ther. 11 (1995) 437-445